What Nexentria does

Nexentria Inc. is a privately-held SaaS company founded in 2023 and headquartered in San Francisco that sells an AI-powered Medical Information (MI) management platform to pharmaceutical and life sciences organizations. The platform unifies MI inquiry handling, Adverse Event (AE) and Product Quality Complaint (PQC) intake, AI-assisted content creation, real-time analytics, and integrated telephony across five modular products that customers can adopt individually or as a full end-to-end suite. Core technical components include an AI Co-Pilot using natural language processing for inquiry triage and response drafting, a generative AI engine that produces compliant Standard Response Documents (SRDs) and summaries, a Compliance Co-Pilot that flags content risk before distribution, AI autodetection for safety and quality events, and integrated telephony with call recording and transcription. The product is built for omni-channel intake, version-controlled content lifecycle management, multilingual support, and 360-degree audit readiness, with claimed GDPR, ISO 9001, ISO 27001, and HIPAA compliance.

The company targets three primary customer segments: small-to-mid-size life science brands, large pharmaceutical brands, and Contract Research Organizations (CROs) serving multiple sponsors. Its go-to-market is an enterprise field sales motion with quote-based modular pricing, multi-year SaaS contracts, and a demo-driven conversion funnel; pricing is not publicly disclosed. Distribution is direct (no channel partners disclosed) and the platform is positioned to integrate with customers' existing CRM, pharmacovigilance, and regulatory systems. Only one customer is publicly named — Biomapas, a global CRO — and the platform is described as capable of scaling from 5 to 50,000 inquiries per week. The company is led by co-founders Vilius Fokas (CEO, formerly at Biomapas and Avon), Stavros Tsompanidis (CPO, formerly at BMS, BioNTech and Intercept Pharmaceuticals), and Maksim Yankovskiy (CTO, formerly at Siemens Medical Solutions, Acuson and Zettaset SafeNet/Thales). No funding rounds, revenue figures, or institutional investors are disclosed in the available source material.

Name

Nexentria

Legal name

Nexentria Inc.

Website

https://nexentria.com

Company type

Private

Founded year

2023

Operating status

Operating

Headcount range

11–50 employees

Short description

Nexentria sells a modular, AI-powered Medical Information management SaaS platform to pharmaceutical brands and CROs, unifying MI inquiry handling, adverse event and product quality complaint intake, generative AI content creation, analytics, and integrated telephony with built-in regulatory compliance.

Ownership category

akta.pro rank

Product category

Pharmaceutical Medical Information Software

NAICS

Software Publishers (5132), Software Publishers (513210)

SIC

Services-Prepackaged Software (7372)

akta.pro primary industry

Adherence, Reminders & Engagement Automation (Medication/Follow-up) (HLACAEAJ)

akta.pro secondary industries

B2B SaaS & Enterprise Personalization (CRM, Sales, Support) (HDAAAGAJ), Customer Engagement & Messaging (Email, SMS, Push, In-App) (BPAFAFAI)

Keywords

• Medical information management
• Pharmaceutical AI platform
• Adverse event intake
• Generative AI content
• Integrated telephony solutions

Headquarters

HQ city

San Francisco

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Marketing or Sales, Operations

Revenue model

1. SaaS Subscription: Modular SaaS platform with subscription-based pricing. Customers can purchase individual modules (MI Inquiry Management, AI Content Creation, Real-Time Analytics, Integrated Telephony, Unified AE/PQC Intake) or the full platform. Flexible pricing allows starting with one module and scaling to all-in-one platform

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

Nexentria sells a modular, AI-powered Medical Information (MI) SaaS platform for pharmaceutical brands and Contract Research Organizations (CROs). The platform combines an AI Co-Pilot, generative AI content creation, integrated telephony, unified AE/PQC intake, and real-time analytics to capture, triage and resolve medical information inquiries, adverse events, and product quality complaints at scale. Customers can license individual modules or scale to the full end-to-end platform under multi-year, quote-based enterprise agreements.

Product overview

Nexentria offers an AI-powered Medical Information (MI) platform delivered as a modular, all-in-one architecture. The core platform consists of five integrated modules: MI Inquiry Management with AI Co-Pilot (for omni-channel inquiry capture, routing and AI-assisted response), AI Content Creation and Lifecycle Management (for SRD generation and content versioning), Real-Time Analytics and Insights (for dashboards and trend analysis), Integrated Telephony (for call management within the platform), and Unified AE and PQC Intake Tool (for adverse event and product quality complaint handling). Customers can adopt a single module or scale to the full end-to-end platform. The product targets pharmaceutical brands (small-to-mid-size and large) and CROs, with built-in compliance safeguards and enterprise-grade security.

Differentiator

Problem solved

Functional benefit

Products and services

• MI Inquiry Management with AI Co-Pilot Centralized module for capturing, triaging, and routing Medical Information (MI) inquiries across all channels with built-in AI assistance. Includes omni-channel intake forms, customizable routing, voice transcription, and an AI chatbot that surfaces approved-content responses. Designed for pharmaceutical brands and CROs that need end-to-end, auditable inquiry handling.
• AI Content Creation and Lifecycle Management Module for generating, managing, and controlling MI content throughout its lifecycle. Provides AI-powered summaries, compliant SRD creation, a version-controlled repository, approval workflows, multilingual templates, and AI-driven content tagging for reusability. Designed for MI teams that need faster, compliant content authoring with full version history.
• Real-Time Analytics and Insights Dashboard and analytics module providing live MI visibility, AI-driven trend analysis, and operational insights. Includes 360-degree audit readiness from compliance tracking to reporting, with AI-powered data analysis. Designed for MI leaders who need live dashboards and audit-ready reporting.
• Integrated Telephony Full-featured call center integrated directly into the MI platform. Includes IVR, call routing, recording, transcription, playback, voicemail, agent routing, after-hours flows, and automatic linking of call data to inquiry records. Designed for MI teams that need to eliminate standalone telephony and keep calls inside the MI workflow.
• Unified AE and PQC Intake Tool Module for unified capture, triage, and routing of Adverse Events (AE) and Product Quality Complaints (PQC) alongside MI inquiries. Features integrated safety and quality intake, AI autodetection of events, built-in QA, tamper-evident audit trails, and direct integration with safety database and quality management systems. Designed for pharma brands and CROs that need a single intake across MI, AE, and PQC.

Quantifiable outcome

• 2x faster onboarding compared to industry standard
• +1 more outcomes

Named customers1 record

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability7 records

Feature8 records

Scale indicators1 record

Recent moves5 records

Expansion highlights5 records

Direct peers

• ArisGlobal: Provides LifeSphere Safety, Quality, and related pharmacovigilance modules used by pharma for AE/PQC and MI workflows. Closely aligned with Nexentria's unified intake and compliance-focused value proposition for life sciences.
• Indegene: Digital-first provider of commercial, medical affairs, and safety solutions specifically for life sciences. Directly comparable as a tech-enabled specialist operating in the same MI, content, and analytics workflows Nexentria targets.
• Veeva Systems: Dominant SaaS provider for pharma with Vault Medical CRM, Vault Safety, and Vault Quality suites that directly overlap Nexentria's MI, AE, and PQC workflows. Most comparable direct competitor given shared domain, regulatory depth, and enterprise pharma focus.

Broad incumbents

• IQVIA: Largest global CRO with embedded technology and commercial/medical solutions serving pharma MI, safety, and commercial workflows. Comparable at the workflow level but as part of a much broader service and platform portfolio.
• Parexel: Global CRO with significant medical information, safety, and pharmacovigilance services. Overlaps Nexentria's CRO customer segment and MI/AE/PQC workflows but delivered primarily as services rather than a modular SaaS platform.
• Salesforce (Health Cloud / Service Cloud): Enterprise CRM platform used in life sciences for MI and customer engagement workflows. Competes at the platform level for pharma MI teams but lacks Nexentria's domain-specific MI, AE, and PQC automation and compliance guardrails.
• Microsoft (Dynamics 365 Customer Service): Enterprise customer service and engagement platform frequently integrated into pharma support operations. Overlaps at the CRM/ticketing layer but requires extensive customization to match pharma MI regulatory and content workflows.

Regional players

• Ashfield MedComms: Global medical communications and MI services provider under Ashfield (part of Inizio). Competes with Nexentria for MI workflows primarily via human services rather than SaaS, with strong relationships among large pharma.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/nexentria

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Nexentria